An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Tuberculosis Is the Highest It’s Been in a Decade
- blkalertshealth
- March 29, 2024
- 0
NEW YORK — The number of U.S.
CDC investigating botulism-like illnesses linked to Botox
- blkalertshealth
- April 13, 2024
- 0
NBC News has identified a dozen confirmed or suspe